| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $56.6M | +65.8% |
| Cost of Revenue | $30.3M | +72.4% |
| Gross Profit | $26.4M | +58.8% |
| R&D Expense | $6.9M | +11.0% |
| SG&A Expense | $7.1M | +39.5% |
| Operating Income | $10.8M | +193.5% |
| Interest Expense | $589K | -47.1% |
| Pre-tax Income | $463K | -88.4% |
| Income Tax | -$19.6M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -9.3% |
| Accounts Receivable | $19.5M | +528.6% |
| Inventory | $12.9M | +35.4% |
| Current Assets | $40.0M | +86.0% |
| Total Assets | $83.7M | +104.6% |
| Current Liabilities | $13.0M | +66.6% |
| Total Liabilities | $26.1M | +118.4% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | -198.3% |
| Capital Expenditures | $810K | -85.9% |
| Investing Cash Flow | -$810K | +85.9% |
| Financing Cash Flow | $3.4M | +98.9% |
| Free Cash Flow | -$4.1M | -70.6% |
| -4733.1% |
| Net Income | $20.1M | +464.6% |
| EPS (Basic) | $0.02 | — |
| EPS (Diluted) | $0.02 | — |
| Stockholders' Equity |
| $57.6M |
| +98.8% |